Ogunmodede, J., Kolo, P., Katibi, I., & Omotoso, A. (2017). The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients. Ethiop J Health Sci.
শিকাগো স্টাইলে সাইটেশনOgunmodede, James, Philip Kolo, Ibraheem Katibi, এবং Ayodele Omotoso. "The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) Is Not Associated With Qtc Prolongation in HIV Patients." Ethiop J Health Sci 2017.
এমএলএ সাইটেশনOgunmodede, James, Philip Kolo, Ibraheem Katibi, এবং Ayodele Omotoso. "The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) Is Not Associated With Qtc Prolongation in HIV Patients." Ethiop J Health Sci 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.